Carlson Capital L P Exicure, Inc. Transaction History

Carlson Capital L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.71 - $1.36 $7,810 - $14,960	-11,000 Reduced 8.8%	114,000 $82,000
Q2 2023 Aug 10, 2023	SELL	$0.85 - $1.44 $54,485 - $92,304	-64,100 Reduced 33.9%	125,000 $163,000
Q1 2023 May 12, 2023	SELL	$0.78 - $1.58 $18,082 - $36,629	-23,183 Reduced 10.92%	189,100 $164,000
Q4 2022 Feb 14, 2023	BUY	$0.71 - $9.3 $15,820 - $207,231	22,283 Added 11.73%	212,283 $244,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $8.5 $137,701 - $765,008	90,001 Added 90.0%	190,000 $298,000
Q2 2022 Aug 15, 2022	BUY	$2.16 - $6.36 $215,997 - $635,993	99,999 New	99,999 $216,000

287K

Ticker XCUR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,962,580
Market Cap $85.3M
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.